FDA Approves New Non-Opioid Painkiller, Journavx: 'No Addiction Potential'
A participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous ...
Roll Call26d
FDA publishes long-awaited front-of-package labeling proposal
FDA Commissioner Robert M ... Bernie Sanders, I-Vt., who then was chairman of the Committee on Health, Education, Labor and Pensions, slammed Califf last month, asserting that the agency was ...
Hosted on MSN20d
FDA approves Zydus’ Phase IIb trial of Usnoflast for ALS treatment
Zydus Lifesciences chairman Pankaj Patel said ... The company has also secured orphan drug status for the therapy from the FDA for treating Cryopyrin Associated Periodic Syndrome (CAPS).
Nasdaq10d
Outlook Therapeutics Appoints Faisal G. Sukhtian as Chairman of the Board of Directors
Sukhtian as Chairman of the Board of Directors ... The company is also focused on resubmitting its application to the FDA in the U.S. for the drug's approval. Sukhtian, who has been on the ...